arginyl-glycyl-aspartic acid has been researched along with ganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, T; Mizuguchi, H | 1 |
| Liu, XW; Liu, YQ; Niu, HT; Song, YF; Tian, YX; Wang, DG; Zhao, MJ | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and ganciclovir
| Article | Year |
|---|---|
Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
Topics: Adenoviridae; Animals; Antiviral Agents; Capsid; Capsid Proteins; Cell Survival; Female; Ganciclovir; Genetic Therapy; Genetic Vectors; Humans; Integrins; Liver; Luciferases; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Receptors, Vitronectin; Simplexvirus; Thymidine Kinase | 2002 |
Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
Topics: Adenoviridae; Apoptosis; Cell Line, Tumor; Ganciclovir; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Oligopeptides; Thymidine Kinase; Urinary Bladder Neoplasms; Uroplakin II | 2016 |